Atropine - Medication | Answer Key

University:
Birmingham City University
Course:
B230 | MPharm Pharmacy
Academic year:

2022
Views:

246

Pages:

1
Author:

Enriquearrimadeo2

Atropine Sulfate Anticholinergics PURPOSE OF MEDICATION Expected Pharmacological Action Therapeutic Use Inhibits the action of acteylcholine at postganglionic sites located in the smooth muscle, secretory glands, CNS. Low doses decrease sweating, salivation, respiratory secr Increased . ecreased I and respirator secretions. eversal o muscarinic e ects. Ma have a spasmol ic action on the biliar and GI tracts Complications Medication Administration ro siness, con usion, h erp xia, blurred vision, c oplegia, photophobia, dr e s, m riasis, tach rdia, palpitations, arrh hmias, dr mouth, constipation, impaired GI motilit urinar hesitanc , retention, impotenc Preanesthesia IM, IV, Subcut adults 0.4-0.6 mg 30-60 min pre op Bradycardia IV adults 0.5-1mg, may repeat as needed Contraindications/Precautions ontraindications: h ersensitivit , angle osure glaucoma, accute hemorrhage, tach rdia secondar to cardiac insu icienc or throtoxicosis, obstructive disease o the GI tract se cautiousl in: intra bdominal in ections, prostatic h e Interactions Increase anticholingeric effects with other anticholingerics, including antihistamines. Antacids decrease absorpption of anticholingercs. May increase GI mucosal lesions in patients taking oral potassium chloride tablets. Nursing Interventions ss VS and ECG tracings freq. during IV drug therapy. Report any significant changes in HR or BP or increased ventricular ectopy or angina to HCP. Monitor intake and output. Assess for abdominal distention Client Education Evaluation of Medication Effectiveness Increase in e ects. . r ess o mouth. eversal o muscarinic aution pts to avoid driving or other activities re uiring alertness until response to medication is kno n. Instruct pt o oral rinses, sugarless gum or cand , re h iene ma help relieve dr mouth